Detail

Study ID: Alliance A171601

Title:

A Phase II Trial Assessing the Tolerability of Palbociclib in Combination with Letrozole or Fulvestrant in Patients Aged 70 and Older with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Location:
Bemidji Clinic, Bismarck Region, Fargo Region, Sioux Falls Region, Thief River Falls, Worthington
Principal Investigator:
Preston Steen, MD,Preston Steen, MD,Preston Steen, MD,Preston Steen, MD
Disease:
Breast - Invasive
Stage:
Phase II
Status:
Active - Open to Accrual